Coronavirus Disease 2019 (COVID-19) Information for Cardiologists　― Systematic Literature Review and Additional Analysis ―

Tadafumi Sugimoto; Atsushi Mizuno; Takuya Kishi; Naoya Ito; Chisa Matsumoto; Memori Fukuda; Nobuyuki Kagiyama; Tatsuhiro Shibata; Takashi Ohmori; Shogo Oishi; Jun Fuse; Keisuke Kida; Fujimi Kawai; Mari Ishida; Shoji Sanada; Issei Komuro; Koichi Node

doi:10.1253/circj.CJ-20-0302

This article has now been updated. Please use the final version.

Coronavirus Disease 2019 (COVID-19) Information for Cardiologists　― Systematic Literature Review and Additional Analysis ―

Tadafumi Sugimoto, Atsushi Mizuno, Takuya Kishi, Naoya Ito, Chisa Matsumoto, Memori Fukuda, Nobuyuki Kagiyama, Tatsuhiro Shibata, Takashi Ohmori, Shogo Oishi, Jun Fuse, Keisuke Kida, Fujimi Kawai, Mari Ishida, Shoji Sanada, Issei Komuro, Koichi Node

Author information

Tadafumi Sugimoto
Department of Clinical Laboratory, Mie University Hospital [Japan]
Atsushi Mizuno
Department of Cardiology, St. Luke’s International Hospital [Japan]
Department of Internal Medicine, University of Pennsylvania [United States]
Department of Cardiology, Juntendo University [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Takuya Kishi
Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Naoya Ito
Division of Infectious Diseases, Shizuoka Cancer Center Hospital [Japan]
Chisa Matsumoto
Department of Cardiology, Center for Health Surveillance & Preventive Medicine, Tokyo Medical University [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Memori Fukuda
Department of Cardiology, Keio University Hospital [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Nobuyuki Kagiyama
West Virginia University Heart and Vascular Institute [United States]
Tatsuhiro Shibata
Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine [Japan]
Takashi Ohmori
Department of Transitional Medicine and Palliaitve Care, Iizuka Hospital [Japan]
Shogo Oishi
Department of Cardiology, Himeji Cardiovascular Center [Japan]
Jun Fuse
Well-Being Clinic Komazawa Park [Japan]
Keisuke Kida
Department of Pharmacology, St. Marianna University School of Medicine [Japan]
Fujimi Kawai
St. Luke’s International University Library [Japan]
Mari Ishida
Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Shoji Sanada
Center for Clinical Research and Innovation, Osaka City University Hospital [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]
Issei Komuro
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo [Japan]
Executive Committee, The Japanese Circulation Society [Japan]
Koichi Node
Executive Committee, The Japanese Circulation Society [Japan]
Department of Cardiovascular Medicine, Saga University [Japan]
Information and Communication Committee, The Japanese Circulation Society [Japan]

Keywords: Cardiologist, COVID-19, Heart failure, Infection, Myocardial injury

JOURNAL FREE ACCESS FULL-TEXT HTML Advance online publication
Supplementary material

Article ID: CJ-20-0302

DOI https://doi.org/10.1253/circj.CJ-20-0302

The final version of this article is now available: Vol. 84 (2020), No. 6 pp. 1039-1043

Details

Abstract

Background:Despite the rapidly increasing attention being given to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, more commonly known as coronavirus disease 2019 (COVID-19), the relationship between cardiovascular disease and COVID-19 has not been fully described.

Methods and Results:A systematic review was undertaken to summarize the important aspects of COVID-19 for cardiologists. Protection both for patients and healthcare providers, indication for treatments, collaboration with other departments and hospitals, and regular update of information are essentials to front COVID-19 patients.

Conclusions:Because the chief manifestations of COVID-19 infection are respiratory and acute respiratory distress syndrome, cardiologists do not see infected patients directly. Cardiologists need to be better prepared regarding standard disinfection procedures, and be aware of the indications for extracorporeal membrane oxygenation and its use in the critical care setting.

Corresponding author

Register with J-STAGE for free!